Does VENETOCLAX Cause Hyperleukocytosis? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Hyperleukocytosis have been filed in association with VENETOCLAX (Venclexta). This represents 0.0% of all adverse event reports for VENETOCLAX.
18
Reports of Hyperleukocytosis with VENETOCLAX
0.0%
of all VENETOCLAX reports
9
Deaths
7
Hospitalizations
How Dangerous Is Hyperleukocytosis From VENETOCLAX?
Of the 18 reports, 9 (50.0%) resulted in death, 7 (38.9%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which VENETOCLAX Alternatives Have Lower Hyperleukocytosis Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL